Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
SK bioscience a global innovative vaccine and biotech company committed to promoting human health from prevention to cure announced today that it has received approval from the Human Research Ethics Committee HREC
Recently Porton Pharma Solutions Ltd announced a strategic partnership with Aojin Life Sciences Yixing Co Ltd Aojin Life Sciences Porton will provide comprehensive CDMO services for Aojin in the CMC pharmaceutical research and GMP production of XDC c...
BeiGene Ltda global oncology company plans to change its name to BeOne Medicines Ltd today announced the presentation of new clinical data at the th American Society of Hematology ASH Annual Meeting Exhibition
Agilent Technologies Inc today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation IVDR certification for PDL IHC pharmDx Code SK This CDx assay has previously been CEIVDmarked for sales in the European Union and i...
Nikon and eLabNext partner to enhance data integration between NISElements imaging software and eLabNexts Digital Lab Platform The NISElements eLabNext module allows users to seamlessly exchange experimental details between NISElements and eLabNexts...
Endo Inc announced today that the US Food and Drug Administration FDA has approved commercial production of VASOSTRICT vasopressin injection USP at the companys newest aseptic manufacturing facility in Indore India
Medigene AGan oncology platform company focused on the research and development of T cell receptor TCRguided therapies for the treatment of cancer today announced the selection of Kirsten rat sarcoma viral oncogene homologue
NIPPON SHOKUBAI CO LTD has announced to acquire all shares of Lilac pharma Incto make Lilac pharma a subsidiary on December
A pooled analysis of the TROPIONLung phase and the TROPIONLung phase trials showed datopotamab deruxtecan DatoDXd demonstrated clinically meaningful tumor response in patients with previously treated advanced or metastatic
The European Commission approved Novo Holdings AS acquisition of Catalent Inc Catalent a global contract development and manufacturing organisation headquartered in New Jersey US as well as Novo Nordisks subsequent acquisition of three manufacturing...
